How 'smart' nanoparticles can deliver targeted gene therapy in osteoarthritis
Osteoarthritis is a highly prevalent joint disease that leads to cartilage breakdown, pain and disability, yet there are still no FDA-approved treatments that can slow or reverse its progression. RNA-based therapies hold ...